Veracyte Inc (VCYT)
Debt-to-equity ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 1,175,970 | 1,044,100 | 1,075,200 | 1,096,510 | 421,232 |
Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $1,175,970K
= 0.00
The debt-to-equity ratio for Veracyte Inc, as reflected in the provided data, remains consistently at zero for the period spanning December 31, 2020 through December 31, 2024. This persistent zero ratio indicates that the company has not used any debt financing in its capital structure during these years. Instead, its operations and growth appear to be financed entirely through equity or other non-debt sources. A debt-to-equity ratio of zero suggests a conservative approach to leverage, potentially reducing financial risk associated with debt obligations. Such a profile can imply strong solvency and liquidity positions, but it may also reflect limited use of debt for expansion or operational needs. Overall, the unchanging zero ratio over this timeframe signifies that Veracyte Inc has consistently maintained a debt-free capital structure during these years.
Peer comparison
Dec 31, 2024